| GeneLibs

题目:: Adipose-derived mesenchymal stem cells and regenerative medicine.
作者:: Konno(Masamitsu),Hamabe(Atsushi),Hasegawa(Shinichiro),Ogawa(Hisataka),Fukusumi(Takahito),Nishikawa(Shimpei),Ohta(Katsuya),Kano(Yoshihiro),Ozaki(Miyuki),Noguchi(Yuko),Sakai(Daisuke),Kudoh(Toshihiro),Kawamoto(Koichi),Eguchi(Hidetoshi),Satoh(Taroh),Tanemura(Masahiro),Nagano(Hiroaki),Doki(Yuichiro),Mori(Masaki),Ishii(Hideshi)
状态:: 发布时间2013-04-11 , 更新时间 2013-04-11
期刊:: Dev Growth Differ
摘要:: Adipose tissue-derived mesenchymal stem cells (ADSCs) are multipotent and can differentiate into various cell types, including osteocytes, adipocytes, neural cells, vascular endothelial cells, cardiomyocytes, pancreatic β-cells, and hepatocytes. Compared with the extraction of other stem cells such as bone marrow-derived mesenchymal stem cells (BMSCs), that of ADSCs requires minimally invasive techniques. In the field of regenerative medicine, the use of autologous cells is preferable to embryonic stem cells or induced pluripotent stem cells. Therefore, ADSCs are a useful resource for drug screening and regenerative medicine. Here we present the methods and mechanisms underlying the induction of multilineage cells from ADSCs.
语言:: eng
DOI:: 10.1111/dgd.12049

文献库文献相关信息